Table 2.
Biochemical parameters and bone turnover markers at baseline.
| Alendronate (n = 5) |
Control (n = 7) |
P value | |
|---|---|---|---|
| Ca (mg/dL) | 9.2 ± 0.4 | 9.4 ± 0.5 | NS |
| P (mg/dL) | 3.5 ± 0.6 | 3.3 ± 0.8 | NS |
| wPTH (pg/mL) | 28.5 ± 9.7 | 34.8 ± 12.4 | NS |
| BAP (IU/L) | 10.3 ± 2.3 | 13.0 ± 5.1 | NS |
| 1, 25-(OH)2vitD | 40.3 ± 11.6 | 40.0 ± 17.6 | NS |
| NTx | 21.6 ± 12.3 | 20.0 ± 5.6 | NS |
| eGFR (mL/min/1.73 m2) | 41.2 ± 9.9 | 35.1 ± 6.9 | NS |
Ca: serum calcium; P: serum phosphate; wPTH: serum whole parathyroid hormone; BAP: serum bone-specific alkaline phosphatase; 1, 25-(OH)2vitD: serum 1, 25-dihydroxycholecalciferol; NTx: serum N-terminal telopeptides of bone-specific type I collagen; eGFR: estimated glomerular filtration rate; NS: not significant.